ArticleClinics (Sao Paulo, Brazil)2022
Time-to-event assessment for the discovery of the proper prognostic value of clinical biomarkers optimized for COVID-19.
José Raniery Ferreira JuniorPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.